Philip Morris agrees to sell on UK asthma inhaler maker Ventura after a backlash over its takeover

Philip Morris bought British asthma inhaler maker Vectura for £1.1billion three years agoPhilip Morris International (PMI) has agreed to sell a British asthma inhaler maker after a backlash over its takeover of the company.The tobacco giant, whose brands include Marlboro cigarettes, bought Vectura for £1.1billion three years ago as part of a plan to transform itself into a ‘healthcare and wellness’ group. But the deal sparked anger that a tobacco group should own a company that cures the kind of illnesses that smoking causes. The backlash included Vectura being excluded from a pharmaceutical conference shortly after the deal.PMI has since taken a £520million impairment against the purchase. It has agreed a £150million sale to US conglomerate Molex.DIY INVESTING PLATFORMSAJ BellAJ BellEasy investing and ready-made portfoliosHargreaves LansdownHargreaves LansdownFree fund dealing and investment ideasinteractive investorinteractive investorFlat-fee investing from £4.99 per monthSaxoSaxoGet £200 back in trading feesTrading 212Trading 212Free dealing and no account feeAffiliate links: If you take out a product This is Money may earn a commission. These deals are chosen by our editorial team, as we think they are worth highlighting. This does not affect our editorial independence.Compare the best investing account for you Advertisement Share or comment on this article: Philip Morris agrees to sell on UK asthma inhaler maker Ventura after a backlash over its takeover

View Original Article